Clinical trial
Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial
NCT02002234 is registered in ClinicalTrials.gov with University of the Philippines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial
- Lead sponsor
- University of the Philippines
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 31, 2002
- Completion date
- December 31, 2009
- Enrollment
- 29 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.